S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
NASDAQ:BBIO

BridgeBio Pharma SEC Filings & 10K Form

$38.71
-1.32 (-3.30%)
(As of 12/3/2021 10:21 AM ET)
Add
Compare
Today's Range
$38.26
$39.82
50-Day Range
$38.04
$53.41
52-Week Range
$37.64
$73.50
Volume
3,018 shs
Average Volume
883,457 shs
Market Capitalization
$5.70 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.77

BridgeBio Pharma (NASDAQ:BBIO) SEC Filings

DateFilerForm TypeView
08/26/2021
3:35 PM
BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/18/2021
3:06 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
5:08 PM
BridgeBio Pharma (Issuer)
SCHELLER RICHARD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
3:49 PM
BridgeBio Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2021
7:00 PM
BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:38 PM
BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:21 PM
BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:16 PM
BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:15 PM
BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:08 PM
BridgeBio Pharma (Issuer)
SAUNDERS BRENT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:03 PM
BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:51 PM
BridgeBio Pharma (Issuer)
SCHELLER RICHARD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:47 PM
BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:45 PM
AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
3:31 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
6:41 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2021
5:29 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
5:28 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
4:30 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2021
4:07 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
3:38 PM
BridgeBio Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2021
4:05 PM
BridgeBio Pharma (Filer)
Form DEF 14A
03/31/2021
6:35 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2021
5:03 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
4:25 PM
BridgeBio Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2021
7:33 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:45 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
5:21 PM
BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:36 PM
BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:28 PM
BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SC 13D/A
02/16/2021
4:02 PM
BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
Form SC 13G/A
02/16/2021
2:36 PM
BridgeBio Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/12/2021
7:51 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
7:45 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
4:15 PM
BridgeBio Pharma (Filer)
Form 424B7
01/29/2021
6:07 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2021
7:40 PM
BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
3:56 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2021
3:23 PM
BridgeBio Pharma (Subject)
Eidos Therapeutics, Inc. (Filed by)
Form SC 13D/A
01/26/2021
8:00 AM
BridgeBio Pharma (Filed by)
Eidos Therapeutics, Inc. (Subject)
Form SC 13D/A
01/26/2021
7:46 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:20 PM
BridgeBio Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/25/2021
3:18 PM
BridgeBio Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/20/2021
3:19 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2021
3:42 PM
BridgeBio Pharma (Filed by)
Eidos Therapeutics, Inc. (Subject)
Form 425
01/12/2021
6:44 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2021
6:42 AM
BridgeBio Pharma (Filed by)
Eidos Therapeutics, Inc. (Subject)
Form 425
01/04/2021
3:31 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
3:30 PM
BridgeBio Pharma (Filed by)
Eidos Therapeutics, Inc. (Subject)
Form 425
12/29/2020
8:14 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
4:35 PM
BridgeBio Pharma (Issuer)
SCHELLER RICHARD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
3:05 PM
BridgeBio Pharma (Issuer)
SCHELLER RICHARD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:05 PM
BridgeBio Pharma (Issuer)
Sinha Uma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:05 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:05 PM
BridgeBio Pharma (Issuer)
SCHELLER RICHARD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
11:15 PM
BridgeBio Pharma (Filer)
Form EFFECT
12/15/2020
8:26 AM
BridgeBio Pharma (Filer)
Form DEFM14A
12/15/2020
8:22 AM
BridgeBio Pharma (Filer)
Form 424B3
12/11/2020
6:11 AM
BridgeBio Pharma (Filer)
Form S-4/A
12/02/2020
3:17 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:05 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
8:54 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
7:44 PM
BridgeBio Pharma (Issuer)
YAU YI CHING (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:51 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:43 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:43 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:39 PM
BridgeBio Pharma (Issuer)
Sinha Uma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:38 PM
BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:05 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
4:05 PM
BridgeBio Pharma (Filer)
Form S-4
Registration statement under Securities Act of 1933  
11/06/2020
7:36 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
4:07 PM
BridgeBio Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
7:00 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
3:05 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
3:30 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
8:14 PM
BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:17 PM
BridgeBio Pharma (Subject)
Eidos Therapeutics, Inc. (Filed by)
Form SC 13D
10/06/2020
4:18 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
4:16 PM
BridgeBio Pharma (Subject)
Form 425
10/06/2020
3:45 PM
BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SC 13D/A
10/05/2020
8:58 PM
BridgeBio Pharma (Filed by)
Eidos Therapeutics, Inc. (Subject)
Form 425
10/05/2020
4:30 PM
BridgeBio Pharma (Filed by)
Eidos Therapeutics, Inc. (Subject)
Form SC 13D/A
10/05/2020
4:19 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
4:17 PM
BridgeBio Pharma (Subject)
Form 425
10/02/2020
6:57 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:05 PM
BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
6:02 PM
BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
6:01 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2020
6:07 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2020
6:05 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
3:05 PM
BridgeBio Pharma (Issuer)
SCHELLER RICHARD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
5:38 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
3:05 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:06 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:05 PM
BridgeBio Pharma (Issuer)
Turtle Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
6:09 PM
BridgeBio Pharma (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
6:03 PM
BridgeBio Pharma (Issuer)
Sinha Uma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
6:02 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
6:02 PM
BridgeBio Pharma (Issuer)
Stolz Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
5:59 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.